Business Context and Reporting Period
This Form 8-K filing by IRIDEX Corporation (IRIDEX) covers the event date of December 5, 2012. The report details a corporate governance change involving the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the appointment of Scott A. Shuda to the Board of Directors on December 5, 2012. This appointment was made pursuant to a Securities Purchase Agreement dated August 31, 2007, between IRIDEX and BlueLine Capital Partners ("BlueLine"). Under the agreement, BlueLine holds the right to designate two individuals to the Board. Mr. Shuda is the director designated in the sole discretion of BlueLine, while James B. Hawkins continues to serve as the director designated by BlueLine subject to Company approval.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. It notes that Mr. Shuda's compensation as a non-employee director will be determined by the Compensation Committee and that he is expected to execute the Company's standard form of indemnification agreement. No risks, contingencies, or unusual items are disclosed in this specific filing.
Important Facts for Investor Verification
- Scott A. Shuda, co-founder and Managing Director of BlueLine Partners, LLC, was appointed to the IRIDEX Board of Directors on December 5, 2012.
- The appointment fulfills a contractual right granted to BlueLine Capital Partners under a 2007 Securities Purchase Agreement.
- Mr. Shuda brings experience in technology and healthcare sectors, including prior roles at Vicinity Corporation and MGC Diagnostics Corporation.
- Mr. Shuda's specific compensation package has not been disclosed and will be set by the Compensation Committee.